Cellares

Cell therapy manufacturing services provider

Healthcare
B2B
Biology
Social Impact

See open opportunities

Company mission

To enable the cost-effective parallel production of thousands of cell therapy doses per month.

Employees

101-200

HQ Location

The East Side, South San Francisco, CA

OTTA INSIGHTS

Few candidates hear
back within 2 weeks

44% employee growth in 12 months

Otta's take on Cellares

Xav Kearney headshot

Xav Kearney

CTO of Otta

Cellares has adopted an innovative role in the automation of cell therapy manufacturing. Cellares argues that the potential of cell therapy is limited by manufacturing bottlenecks, and so its scalable solution makes a huge contribution to this space.

The company's manufacturing system, the Cell Shuttle, is set to be the solution needed to ensure that cell therapy isn't held back by disjointed, cost-prohibitive, and failure-prone procedures. This "factory in a box" houses the instruments needed to handle cells and turn them into therapies and could be market ready by 2024.

The potential for expansion in this niche is massive, as only 10% of the required manufacturing capacity for this field exists today. Cellares is therefore tapping into this market with a robust, cost-effective solution. Its automation, flexibility, and scalability will be hugely valuable to many businesses. Since the automation of systems in this field can result in a 70% cost reduction, this gives the company a competitive edge in a sector that is set to heat up soon.

Total funding - $355m

Last 2 fundraises

May 2021

$82m

SERIES B

Aug 2023

$255m

SERIES C

This company has top investors

Company benefits

  • Flexible Work From Home Policy
  • Holidays
  • Professional Development
  • Stock Options
  • Excellent Healthcare
  • 401(k)
  • Free Meals
  • EV Charging

Company values

  • A meaningful purpose. We believe that the technology we’re developing must benefit society in general and patients in particular. We are dedicated to creating a world in which life-saving cell therapies are available to patients in need.
  • A collaborative culture. We’re creating a diverse and inclusive culture in which individuals are safe to take risks, free to bring their whole selves, enjoy shared leadership and have fun along the journey.
  • An audacious adventure. We are taking on a daring challenge. We’re pioneering a new manufacturing paradigm for a new class of therapeutics. You have an opportunity to make history and leave a legacy!

Founders

Omar Kurdi

(President)

Electrical Engineering at San Jose State. Engineer at Thermo Fisher Scientific and Finesse Solutions, before becoming VP at Finesse then Synthego. Co-founded Cellares in 2019.

Masters Degree in Aerospace Engineering at University of Munich. Chief Innovation Officer at Synthego, before co-founding Cellares in 2019.


For companies

Claim your profile to receive high quality applications from relevant candidates.

Claim profile

For job seekers

Sign in or sign up to discover relevant roles at exciting companies.

Sign in or sign up

Cellares is hiring for 5 jobs on Otta!


All locations

People, HR, Recruitment

Other Engineering